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Abstract 
BACKGROUND: Fine-needle aspiration cytology (FNAC) of both palpable and non-
palpable breast carcinomas has a high accuracy and sensitivity in dedicated centres. 
It is generally though that low-grade carcinomas have a distinctly lower sensitivity 
due to a discrete cellular atypia that might be difficult to appreciate. Grade 1 
carcinomas make up about 45 % of screening detected breast carcinomas and about 
20 % of symptomatic breast cancers. The aim of this study was to evaluate the 
diagnostic sensitivity of G1 carcinomas and identify the critical features in the 
cytological diagnostic work-up of these tumours. 
MATERIAL AND METHODS: There were FNAC smears from 494 histologically 
confirmed grade 1 carcinomas diagnosed during 1996-2004. The cytological 
diagnoses were compared with the histology. 
RESULTS: A definitive malignant diagnosis was given in 382 cases (77.3 %). 16.2 % 
were diagnosed as equivocal or suspicious, 4.8 % had been given a benign or 
probable benign diagnosis (false negatives). 13 cases (2.6 %) were unsatisfactory. 
The complete sensitivity was 92.7%. Invasive ductal carcinomas comprised 81.3 % of 
all cases. A definite malignant preoperative diagnosis was given in 80.8 % of these. 
Invasive lobular and tubular carcinomas comprised 7.1 % and 5.5 % of cases, 
respectively. They received a definitive, malignant preoperative diagnosis in 51.4 % 
and 55.6 %, respectively. 
CONCLUSION:  Preoperative FNAC diagnosis of grade 1 breast carcinoma has a 
high accuracy and sensitivity, especially in ductal carcinomas. Invasive lobular and 
tubular carcinomas receive a definite preoperative diagnosis in about 50 % of the 
cases. The main reason for not reaching a definitive malignant diagnosis was 
sampling error due to small tumours < 1 cm in diameter, irrespective of tumour 
subtype. 
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Introduction 
Fine needle aspiration cytology (FNAC) is an integral part of the preoperative 
multidisciplinary triple approach in the work-up of both symptomatic and screening 
detected breast lesions in many institutions. Breast FNAC of palpable and non -
palpable lesions is reliable and cost effective. The literature reports sensitivity and 
specificity ranging from around 60 % to 100 %. (1-23) When integrated into the 
assessment process, it reduces the benign biopsy rate (24). When integrated in the 
triple test, the chance of detecting a malignant lesion is well over 99 %.  
The breast cancer screening programme in Norway has caused a considerable 
increase in the incidence of low-grade carcinomas. The first screening rounds 
showed that up to 45 % of detected carcinomas were histological grade 1 (25) in 
contrast to about 20 % in symptomatic tumours.  It has been generally assumed that 
the accuracy in diagnosing low-grade breast carcinomas on FNAC is substantially 
lower than in grade 2 and 3 carcinomas, resulting in a high degree of false negative 
diagnoses in grade 1 breast carcinomas and hence in a large proportion of screening 
detected breast carcinomas. Some studies have shown that a significant number of 
false negatives may be caused by interpretation failure of certain histological 
subtypes, such as lobular (ILC), tubular (TUB), adenosquamous and papillary 
carcinomas (26;27). The aim of this study was to investigate our results of FNAC on 
histological grade 1 symptomatic and screening detected breast carcinomas. 
Material and methods 
Records from 839 cases of histological grade 1 breast carcinomas diagnosed during 
1996 – 2004 were retrieved from the files of the department of Pathology, Ullevaal 
University Hospital (UUS). About 1/3 had been preoperatively investigated outside 
UUS and FNAC was not available. Smears submitted from one external radiologist 
were omitted, and only cases where the cytopathologists in our department had done 
the aspiration were primarily included. Cases which on review revealed a dominant 
DCIS on histology and where it was obvious that cell material from the DCIS 
component was predominant in the smears were excluded. Lastly, the relevant, 
diagnostic smears could not be found in two cases. This left us with FNAC from 494 
histological confirmed grade 1 carcinomas. Both Papanicolaou (ethanol spray 
fixation) and Giemsa (air dried and methanol fixed) stained smears were evaluated. 
The general diagnostic cytological categories and criteria used in the department are 
given in table 1. 
TNM and grading was taken from the pathology records. The grading had been done 
according to Elston and Ellis’ modification of Bloom and Richardson (28;29). The 
histological grading was not reviewed. The preoperative cytological diagnoses as well 
as eventual suggestion of subtypes of carcinoma were recorded. The smears were 
also evaluated for amount of cell material (scant, moderate or abundant) as well as 
microcalcifications and myoepithelial cells. 
In addition the type of error was evaluated (interpretation vs. sampling error).  A 
diagnosis of less than “carcinoma” in good quality smears with moderately and/or 
abundant cellularity was evaluated as interpretation error. Suboptimal smears with 
any kind of technical fault (crush artefacts, improper fixation) and/or scant cellularity 
were regarded as sampling error.  This included smears with no or a limited number 
of benign appearing epithelial cells where it was obvious that the tumour had been 
missed on aspiration. 
One observer (MK) evaluated 380 cases independently as part of a medical student’s 
project. 242 of these were also evaluated by joint microscopy by the two observers. 
Observer two (TS) evaluated the rest independently and overruled observer one in 
cases of discrepancies. The rest of the cases were evaluated by TS alone. As this 
was a student’s project, no inter observer evaluation was done. 
 
 
Results 
80.3 % of the carcinomas were pT1, 18.2 % were pT2 and 1.5 % pT3 and pT4, 
respectively. 50.1 % of cases were N0, 16.6 % were N+ and 33.3 % were NX. 
An overview of the other results is shown in tables 2 and 3. There were 4.8% false 
negatives (benign and probably benign cases) (FN) whereas 2.6% were 
unsatisfactory for diagnosis (table 2). 68.8 % of the unsatisfactory cases were from 
tumours < 1 cm in diameter (pT1a and pT1b). Three pT2 cases with unsatisfactory 
FNAC were all ILC. 
The complete sensitivity was 92.5 % (434 cases), whereas the absolute sensitivity 
was 77.3 % (382 cases).   
Invasive ductal carcinomas (IDC) comprised 83.4 % of cases (figure 1). ILC and TUB 
(figures 2, 3A and 3B) made up 5.5 % and 4.5 %, respectively. In 397 (80.3 %) cases 
a cytological subtype was suggested. 89.6 % of the cases described as ductal on 
cytology were concurrent with the histological sub typing, whereas only 40 % of ILC 
and TUB were correctly suggested as subtype on FNAC.  
Sampling error (SE) was the main cause of not reaching a definite diagnosis of 
malignancy on FNAC (66.1 % of cases). In ILC and TUB SE made up > 82 % of 
cases. Scant cell material was found in 19.7 % of cases and made up 86.7 % of 
cases with a benign FNAC diagnosis, 75 % of the probably benign cases and 70 % 
of the equivocal cases. These and 42.9 % of the suspicious cases made up the SE 
cases.  10.1 % were given a definite diagnosis of malignancy in spite of the scant 
cellularity. 
Abundant cell material was noted in 50.7% of the cases. None of these had been 
given a benign diagnosis, but 12.5 % had been diagnosed as probably benign, 10 % 
as equivocal and 18.4 % as suspicious and representing interpretation error (IE) 
cases. Scattered myoepithelial cell nuclei were found at the periphery of epithelial 
(carcinoma) cell groups (but not in the background) in 20.2 % of IDC and 39.1 % of 
TUB. Microcalcifications were found in 45 % of all cases. 
 
 
Discussion 
Sensitivity, percentage of inadequate smears and FN in FNAC of grade 1 breast 
carcinomas are all well within the QC recommendations in the Norwegian breast 
screening programme (21). The sensitivity is marginally lower than in previous results 
from non-palpable breast lesions (22). This is in agreement with the fact that 80 % of 
the carcinomas in this study were < 10 mm and the vast majority would have been 
non-palpable (this feature had not been recorded). In a previous report of the first 
four years of mammography screening in Oslo (21) we found an absolute and 
complete sensitivity of 81 % and 91 %, respectively. The sensitivity of FNAC ranges 
in the literature from 65 to 98 % (7). It reflects both aspirator and interpretation skills. 
FNAC is highly operator dependent (7;30;31). Aspirator skill is also reflected in the 
inadequacy rate, which was 2.6 % in this study. 
 Subtyping of carcinomas on cytological material revealed significant differences 
between IDC, ILC and TUB (table 3). Almost 90 % of IDC were correctly sub-
classified as such on cytology, whereas only 40 % of ILC and TUB were correctly 
sub-classified. Both ILC and TUB have characteristic cytological features reported in 
the literature (32-43), but none of them are restricted to one subtype only. IDC has a 
wide range of histological appearances which may be reflected in FNAC. They 
include features that may also be found in other subtypes. Also, IDC may harbour 
components of other subtypes such as tubular, mucinous, papillary and lobular which 
may be found in the smears. The most important is to recognise a papillary subtype, 
as these may present as a tumour both clinically and radiologically and still be an in 
situ lesion on histology.  The problem of diagnosing in situ versus invasive lesions 
has been addressed previously (21;44). In case of a cytological papillary carcinoma, 
we do not attempt to predict eventual invasive growth. The lesion will be resected 
with free margins, but the sentinel node will not be removed. Apart from that, 
subtyping does not affect the primary management of the women and is not 
essential. 
Sampling error (SE) was the main cause of not giving a preoperative definite 
malignant diagnosis irrespective of tumour type (table 3) and the main cause of SE 
was small tumour size (80 % < 1 cm). In IDC the causes were rather mixed and both 
sampling and interpretation might be a problem.  
Sampling is a well known problem in ILC and is due to the abundant sclerotic stroma 
that is found in most cases. The carcinoma cells usually present with a low - grade, 
but recognizable atypia, but the cells are characteristically few in numbers. The 
characteristic finding in FNAC from ILC would be scant to moderate amount of cells 
(table 3) diagnosed as suspicious (28.6 %) or as malignant (51.4 %) and where the 
reservation in the diagnosis is due to a low number of carcinoma cells on the smears 
(82.4 %, see table 2).  
TUB present little atypia in contrast to most IDC, and may be misdiagnosed as 
fibroadenoma or fibrocystic changes (33;34). Cellular features such as angular 
tubular structures, single epithelial cells, absence of or paucity of bare oval nuclei are 
frequently described as distinguishing features (32;33). TUB represented a diagnostic 
problem as they frequently eluded detection on cytology. 8 (30 %) cases were 
diagnosed as benign, probably benign or equivocal. 55.6 % (= absolute sensitivity) 
was given a definitive preoperative diagnosis in our study, whereas the complete 
sensitivity (malignant + suspicious + equivocal) was 85 %. Mitnick et al. (42) showed 
an absolute sensitivity of 42 %, which is somewhat lower than our findings. 
Cangiarella et al. (33) showed a complete sensitivity of 86 %.  Despite the discrete 
cellular and nuclear atypia of TUB, the main cause of not reaching a definitive 
malignant diagnosis in our material was sampling (table 2). 
Although there is a higher false negative rate of TUB and ILC than of ductal 
carcinoma, the combined incidence comprised only 10 % of the total number of 
cases. Overall, ILC will make up a larger group, though, as many of them are 
diagnosed as grade 2 (G2). 
There has been an increase in the use of core biopsy (CNB) in the recent years 
(45;46). CNB has a higher sensitivity for ILC and TUB (42), but considering the 
incidence, it would be cost efficient and time saving to use FNAC as a first line 
investigation. Combination of CNB and FNAC has shown a higher sensitivity than 
FNAC alone (12). However, if the sensitivity of FNAC is high, the additional value of a 
CNB will have a marginal effect on the sensitivity. In addition, sampling of small and 
focal lesions is known to cause diagnostic difficulties even in CNB (47).  
Myoepithelial cells were found in a subpopulation of IDC and TUB (20 % and 39 %, 
respectively), but always in limited numbers. It is important to know this and not 
diagnose these lesions as benign or probably benign on account of a few 
myoepithelial cells. 
Microcalcifications were a common finding in IDC and TUB (45 % and 65 %, 
resepectively), but were non-contributory in the diagnostic work-up.  
In conclusion, FNAC had a high sensitivity in diagnosing low - grade invasive 
carcinomas. The main difficulties encountered were related to SE, irrespective of 
tumour subtype. Small tumour size was the main cause of SE. In contrast to what 
might have been anticipated, IDC had the largest proportion of interpretation 
problems. 
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Table1. Diagnostic categories and criteria 
 
Cytological diagnostic categories Cytological diagnostic criteria 
unsatisfactory No/(too few epithelial cell groups present 
Benign NOS Sheets/groups of benign apocrine and/or 
ductal epithelial cells; a variable number 
of naked (myoepithelial) nuclei in the 
background and recognisable 
myoepithelial nuclei on a number of 
benign epithelial sheets and groups 
Equivocal Epithelial cells with nuclear changes of 
uncertain significance 
Suspicious for carcinoma Epithelial cells with some, but not 
sufficient diagnostic features of 
carcinoma; often scant cell material 
Carcinoma Variable, buy most often a high cell yield; 
single population of atypical epithelial 
cells in irregular and angular clusters; 
reduced cohesiveness, variable, nuclear 
enlargement and irregularity; single cells 
with intact cytoplasm; absence of naked 
(myoepithelial)  nuclei in the background 
 
 
Table2.Cytologic diagnoses 
 frequency percent 
unsatisfactory 13 2.6 
benign 16 3.2 
Hyperplasia/ 
Probably benign 
8 1.6 
Equivocal 23 4.7 
Suspicious for 
carcinoma 
52 10.5 
Invasive carcinoma 382 77.3 
total 494  
 
 
 
 
 
 
 
 
 
Table3. Results of cytologic subtype, cytologic diagnosis, type of error, amount of cell 
material and microcalcification compared to histologic subtype. 
                                                                     Histologic subtype 
 ductal lobular tubular mucinous papillary other subtotal
Cytologic subtype 
(when suggested = 
397 cases) 
) 
       
 carcinoma 
NOS 
106 
(86.2%) 
11 4 2 0 0 123 
 ductal 206 
(89.6%) 
5 10 1 1 7 230 
 lobular 6 6 
(46.2%)
1 0 0 0 13 
 tubular 2 0 2 
(40%) 
0 0 1 5 
 mucinous 4 0 1 11 
(68.8%) 
0 0 16 
 papillary 5 0 0 0 2 1 8 
 other 2 0 0 0 0 0 2 
subtotal 331 
(83.4%) 
22 
(5.5%) 
18 
(4.5%) 
14 3 9 397 
        
Cytologic diagnosis 
(= 494 cases) 
       
 unsatisfactory 9 3 1 0 0 0 13 
 benign 12 1 3 0 0 0 16 
 probably 
benign 
6 2 0 0 0 0 8 
 equivocal 15 1 4 2 0 1 23 
 suspicious for 
carcinoma 
35 
(8.7%) 
10 
(28.6%)
4 
(14.8%)
1 0 2 52 
 invasive 
carcinoma 
325 
(80.8%) 
18 
(51.4%)
15 
(55.6% 
14 
(82.4) 
3 7 382 
Type of error (in 
cases not having a 
definitive malignant 
preoperative 
diagnosis = 112 
cases) 
       
 interpretation 
error (IE) 
31 
(40.3%) 
3 
(17.6%)
2 
(16.7%)
1 0 1 38 
(339%) 
 sampling 
error (SE) 
43 
(57.9%) 
14 
(82.4%)
10 
(83.3%)
2 0 2 74 
(66.1%)
        
Amount of cell 
material (evaluated 
in 470 cases) 
       
 scant 67 13 9 2 0 2 93 
(17.4%) (41.9%) (36%) (11.8%) 
 moderate 111 
(28.9%) 
13 
(41.9%)
7 
(28%) 
5 
(29.4%) 
0 2 138 
 abundant 206 
(53.6%) 
5 
(16.1%)
29 
(36%) 
10 
(58.8%) 
3 10 239 
        
Microcalcification 
(evaluated in 451 
cases) 
       
present 173 5 15 4 1 6 204 
not present 198 24 8 12 2 3 247 
subtotal 371 29 23 16 3 9 451 
 
 
